DrugPatentWatch Database Preview
Seqirus, Inc Company Profile
Email this page to a colleague
See Plans and PricingUS Patents for Seqirus, Inc
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Number | Approval Date | Patent No. | Assignee | Estimated Patent Expiration | Status | Orphan | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Seqirus, Inc. | FLUCELVAX QUADRIVALENT | influenza a virus a/idaho/07/2018 (h1n1) antigen (mdck cell derived, propiolactone inactivated, influenza a virus a/indiana/08/2018 (h3n2) antigen (mdck cell derived, propiolactone inactivated), influenza b virus b/singapore/inftt-16-0610/2016 antige | INJECTION, SUSPENSION | 125408 | 1 | 2016-05-23 | ||||||
| Seqirus, Inc. | FLUAD | influenza vaccine, adjuvanted | INJECTION, SUSPENSION | 125510 | 1 | 2015-11-24 | 9,821,051 | Seqirus UK Limited (Berkshire, GB) | 2030-10-28 | search | ||
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Number | >Approval Date | >Patent No. | >Assignee | >Estimated Patent Expiration | >Status | >Orphan | >Source |
Similar Applicant Names
Companies are sometimes listed under multiple names.
This search can help find similar names.
This search can help find similar names.
